New Guidelines Recommend Daily HIV Prevention Pill for Those at Substantial Risk

May 14, 2014 – New Guidelines Recommend Daily HIV Prevention Pill for Those at Substantial Risk

New clinical guidelines recommend that health care providers consider pre-exposure prophylaxis (PrEP) for patients at substantial risk for HIV. PrEP is the use of anti-HIV drugs by people who do not have HIV to reduce the risk of infection.

For your stories about the new guidelines, please find below a press release – which provides key facts about PrEP and also outlines the specific indications for which PrEP is recommended – as well as other useful background resources on HIV.

Resources

You may download/link the following options of broadcast quality video and audio featuring NCHHSTP Director Jonathan Mermin, MD, MPH, talking about the new clinical guidelines that recommend health care providers consider pre-exposure prophylaxis (PrEP) for patients at substantial risk for HIV. Please note that these resources are for media use/reprint. If you are a member of the general public and seek additional information about HIV, please visit www.cdc.gov/hiv. If you have additional questions, please call 1(800) CDC INFO or email CDC-INFO.

Why is it Important?

Watch the Video: Protecting Yourself and Your Partners from HIV

 

What are the Key Points?

Video clip of Dr. Jonathan Mermin talking about the Key Points of PrEP
Page last reviewed: May 14, 2015